652 related articles for article (PubMed ID: 29340759)
21. [Cytomegalovirus enteritis after allogeneic hematopoietic stem cell transplantation].
Yin YM; Wu T; Ji SQ; Da WM; Zhao YL; Wang JB; Cao XY; Lu Y; Sun Y; Tong CR; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):516-20. PubMed ID: 22338172
[TBL] [Abstract][Full Text] [Related]
22. Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity.
Herling M; Schröder L; Awerkiew S; Chakupurakal G; Holtick U; Kaiser R; Pfister H; Scheid C; Di Cristanziano V
J Clin Virol; 2016 Jan; 74():57-60. PubMed ID: 26672492
[TBL] [Abstract][Full Text] [Related]
23. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
Du J; Liu J; Gu J; Zhu P
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
[TBL] [Abstract][Full Text] [Related]
24. A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group.
George B; Kerridge IH; Gilroy N; Huang G; Hertzberg MS; Bradstock KF; Gottlieb DJ
Transpl Infect Dis; 2012 Apr; 14(2):141-8. PubMed ID: 22283838
[TBL] [Abstract][Full Text] [Related]
25. Graft-Versus-Host Disease With Early Cytomegalovirus Infection in Gastrointestinal Tract Biopsies.
Sun BL; Jain R; Patel C; Bhattacharyya AK
Int J Surg Pathol; 2018 Jun; 26(4):347-352. PubMed ID: 29207904
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.
Gilles R; Herling M; Holtick U; Heger E; Awerkiew S; Fish I; Höller K; Sierra S; Knops E; Kaiser R; Scheid C; Di Cristanziano V
Med Microbiol Immunol; 2017 Oct; 206(5):355-362. PubMed ID: 28702856
[TBL] [Abstract][Full Text] [Related]
27. Choice of Endoscopic Procedure in Children With Clinically Suspected Gastrointestinal Graft-versus-host Disease.
Mårtensson T; Szakos A; Mellgren K; Toporski J; Arvidson J; Casswall TH; Gustafsson B
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):744-750. PubMed ID: 29045348
[TBL] [Abstract][Full Text] [Related]
28. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
[TBL] [Abstract][Full Text] [Related]
29. Villous atrophy in the terminal ileum is a specific endoscopic finding correlated with histological evidence and poor prognosis in acute graft-versus-host disease after allo-hematopoietic stem cell transplantation.
Sugihara Y; Hiraoka S; Fujii N; Takashima S; Yamasaki Y; Inokuchi T; Takahara M; Kuwaki K; Harada K; Tanaka T; Okada H
BMC Gastroenterol; 2018 Jul; 18(1):111. PubMed ID: 29996762
[TBL] [Abstract][Full Text] [Related]
30. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.
Yanada M; Yamamoto K; Emi N; Naoe T; Suzuki R; Taji H; Iida H; Shimokawa T; Kohno A; Mizuta S; Maruyama F; Wakita A; Kitaori K; Yano K; Hamaguchi M; Hamajima N; Morishima Y; Kodera Y; Sao H; Morishita Y
Bone Marrow Transplant; 2003 Oct; 32(8):801-7. PubMed ID: 14520425
[TBL] [Abstract][Full Text] [Related]
31. Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan.
Huang YC; Hsiao FY; Guan ST; Yao M; Liu CJ; Chen TT; Lin TL; Liu YC; Chen TY; Hong YC; Ma MC; Tan TD; Wang CC; Wu YY; Liao PW; Wu YF; Chen YY; Yu YB; Hsieh YY; Lee MY; Liu JH; Lin SW; Ko BS
J Microbiol Immunol Infect; 2024 Jun; 57(3):365-374. PubMed ID: 38503632
[TBL] [Abstract][Full Text] [Related]
32. [Cytomegalovirus infection monitoring in patients with long-term survival after allogeneic hematopoietic stem cell transplantation].
Chen L; Luo Y; Hu Y; Tan Y; Zhao Y; Fan J; Huang H
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3145-9. PubMed ID: 25573309
[TBL] [Abstract][Full Text] [Related]
33. [Research Progres on Relationship between the Graft-Versus-Host Disease and Cytomegalovirus Infection--Review].
Xie WX; Huang WF; Tu SF; Li YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):303-6. PubMed ID: 26913442
[TBL] [Abstract][Full Text] [Related]
34. Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation.
Xiao Y; Song J; Jiang Z; Li Y; Gao Y; Xu W; Lu Z; Wang Y; Xiao H
Int J Med Sci; 2014; 11(6):652-7. PubMed ID: 24834012
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease.
Cantoni N; Hirsch HH; Khanna N; Gerull S; Buser A; Bucher C; Halter J; Heim D; Tichelli A; Gratwohl A; Stern M
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1309-14. PubMed ID: 20353832
[TBL] [Abstract][Full Text] [Related]
36. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
[TBL] [Abstract][Full Text] [Related]
37. Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis.
Marty FM; Bryar J; Browne SK; Schwarzberg T; Ho VT; Bassett IV; Koreth J; Alyea EP; Soiffer RJ; Cutler CS; Antin JH; Baden LR
Blood; 2007 Jul; 110(2):490-500. PubMed ID: 17392502
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation.
Kawamura S; Nakasone H; Takeshita J; Kimura SI; Nakamura Y; Kawamura M; Yoshino N; Misaki Y; Yoshimura K; Matsumi S; Gomyo A; Akahoshi Y; Kusuda M; Kameda K; Tanihara A; Tamaki M; Kako S; Kanda Y
Transplant Cell Ther; 2021 Aug; 27(8):683.e1-683.e7. PubMed ID: 33984537
[TBL] [Abstract][Full Text] [Related]
39. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
40. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease.
Xu LP; Zhang HY; Huang XJ; Liu KY; Liu DH; Han W; Chen H; Chen YH; Gao ZY; Zhang YC; Lu DP
Chin Med J (Engl); 2007 Oct; 120(19):1666-71. PubMed ID: 17935666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
